In 2023, Moderna conducted an environmental assessment and disclosed corporate waste management data in accordance with recognized sustainability reporting standards. The company provided a breakdown of its waste by type (hazardous vs non-hazardous) and treatment method (recovery vs disposal), enabling greater transparency into its waste handling and environmental practices.
Metric (tonnes) | 2024 | 2023 | 2022 | 2021 - 2017 |
---|---|---|---|---|
Total Waste Generated | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Waste Recovered | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Hazardous Waste Generated | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Non-Hazardous Waste Disposed | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
This table provides a simplified preview of selected waste data points. To access the complete dataset with full disclosures and structure, create a free account to purchase the full dataset.
In 2023, Moderna generated a total of 1,987 metric tonnes of waste.
Of this amount, 15.55% of Moderna's total waste generated was recovered through methods such as recycling, reuse, or composting, while 84.55% was disposed of through landfilling, incineration, or combustion.
In 2023, Moderna reported a total waste generation of 1,987 metric tonnes, of which 15.55% was recovered through recycling, reuse, or composting. This low recovery rate highlights limited waste diversion and suggests that Moderna may be relying more heavily on landfill or incineration, underscoring opportunities for stronger resource recovery initiatives.
Since 2021, Moderna's total waste generation increased by 5.36%, but remained relatively stable in 2023, suggesting that past growth in waste production may have recently plateaued.
Over the same period, Moderna's waste recovery rate declined by 22.2%, with a further 19.54% drop in 2023, underscoring a weakening in waste diversion performance and a potential drift away from circular waste strategies.
Overall, Moderna continues to produce more waste than in earlier years, while falling short on recovery. Recent stagnation in waste output offers little relief if recovery performance continues to weaken.
In 2023, Moderna generated a total of 1,987 metric tonnes of waste.
Of this amount, 18.27% of Moderna's total waste generated of was classified as hazardous waste, characterized by properties such as toxicity, flammability, corrosiveness, or reactivity that may pose risks to human health, ecosystems, or the environment. 81.78% was identified as non-hazardous waste, generally considered less harmful and subject to lighter regulatory controls.
Since 2021, Moderna's total waste generation increased by 5.36%, including a 0.4% rise in 2023, reflecting a persistent upward trend that could be linked to operational growth, inefficient material use, or limited investment in waste prevention systems.
Over the same period, Moderna reduced the hazardousness of its waste by 6.88%, with a further 3.84% decline in 2023, suggesting a sustained and meaningful shift toward safer waste profiles and lower environmental impact.
Overall, Moderna's waste and hazardousness trends are mixed or inconclusive. A more detailed review of its materials, industry standards, and operational changes would help clarify the net environmental impact of its waste strategy.
In 2023, Moderna reported that 363 metric tonnes of its total waste output were classified as hazardous. This represents 18.27% of its overall waste generation.
The company treated this hazardous waste using a combination of methods. Only 0.83% of hazardous waste was recovered, meaning the vast majority was treated through disposal methods such as landfilling or incineration. This raises concerns about the environmental and health risks associated with Moderna’s current hazardous waste practices.